Get Free Access
TZ Ref No.: TZ-1142764

Dk 021:2015 - 33600000-6 - pharmaceutical products (epinephrine 1.82 mg/ml, solution for injections, ampoules; 500 mg azithromycin tablets/ capsules; human insulin (short-acting), solution for injecting, 100 mg/mL, vials, 10 ml; ammonia, solution...

Doc ref no. -
Sector Pharmaceuticals, Healthcare Equipment and Services, Healthcare and Medicine
Publish Date 03 Oct 2026
Estimated Value UAH 1.6M
Tender Intelligence
Qualification analysis + key highlights for this procurement

TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.

A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.

Sign in to unlock Bid Fit & AI Opportunity Intelligence

TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).

Description & Project Overview

Dk 021:2015 - 33600000-6 - pharmaceutical products (epinephrine 1.82 mg/ml, solution for injections, ampoules; 500 mg azithromycin tablets/ capsules; human insulin (short-acting), solution for injecting, 100 mg/mL, vials, 10 ml; ammonia, solution to be used for external use, 10%, 100 ml; Amoxicillin and Clavulonic acid, powder for injection/infusion; Amlodipine tablets, 10 mg; Albumin, solution, 20%, 100ml; Methazoles, solution of injection, 500 mg/ ml; Amethyl, 1 ml; 3 ml; 1 ml of amethyl; 1 mg of amethole; 1 to 1 ml, 1 to 5 ml; 50 ml of acetaminophenic acid, 1 mg; 1 mL of acetate, 1 mO; 1 oz; 1ml of acetyl, 2 ml of sodium, 1 oz, 1 or 1 oz of acetylene; 1 g of acetatohexane, 1 g; 1 ppm of acetates, 1 p.benzylbenzoate thick emulsion, 200 mg/h, 50 g in vial; bisoprolol tablets of 5 mg; simvastatin tablets, coated with a film coating, 20 mg; vancomycin leophilisate/ powder for infusion solution of 500 mg; warfarin tablets; tablets for 2.5 mg; water for 5 ml ampoule injections; charcoal active tablets/ capsules of 250 mg; haloperidol tablets with solution for injection, 5 mg/mL, 1 ml; translucent acid solution for injectation, 100 mg/ml, 5 ml; traxamocide solutions for injections, 50 mg/mm; 5 ml for injectioneering, 25 mg/mg; 2 ml for 40 mg/min; 10 ml for injection, 10 ml/min for injectable; 2 mg/mil for injectables, 10 mg/mo; 10 mg for injects, 10 mm; 2 mm for injecting, 10 mL; 5 mm for hydrolysis, 10ml/min, 10%, for injected, 10 g/m; 10 mm for in injections for injectants, 10glucose of 5% solution for infusions at 200 ml; dexamethasone, solution for injections at 4 mg/ ml; diclofenac solution for injectations at 25 mg/ml; fluconazole, solution to infusions, at 2 mg/ mL, at 100 ml; enalapril tablets at 10 mg; enallapril tablet at 5 mg; theophylline solutions for injection at 20 mg/ mmL; cephthazidim powder for injects at 1.0 g; ibuprofen, oral suspension, at 50 mg/ mg; isoburchinide, concentrate/ ml, at 10 ml; etrophyamide under titration, at 20 mmL/ mI; 20 mg / mI, at 200 mg; 20 mmI, for injectible chloride; 20 ml/ mC; 20mg/ mO; 20 g/ mP; 20 Mg/ mE; 20 mO for injectable chlorine; 20 milligrams for injectables at 100 mg/mI; 10 mg for injective chlorine, at 75 mg/M; 20Carvedidol tablets at 12.5 mg; acetylsalicylic acid tablets 75 mg; clarithromycin tablets, coated with a coating, at 500 mg; levofloxacin, pills at 500mg; levoloxacin solution for infusions, at 5 mg/mL, at 100 ml; douredinidine, coating with a film coating at 10 mg; linoleic acid tablet, at 600 mg; lidocaine, solution for injections, at 20 mg/ml, at 2 ml; lidocain, spray, at 10%, at 38 g; lopperimidine tablets/capsules at 2 mg; mannatidine tablet at 10 g; magnesium sulphate, at 1 mg; solvent for injection, at 250 mg / ml; powder, at 50 mg / mL; powder for injecting, at 400 mg; 50 mg/ ml, at 200 mg, at 150 mg, for injectable fluoxetine; 5 mg, injected, at the rate of 100 mg;2 ml; metformin tablets/capsules of 500 mg; metronidazole tablet/capsule of 250 mg; metronnidazole, solution for infusion, 5 mg/ml of 100 ml; moxifloxacin solution for perfusion, 400 mg/250 ml of 250 ml; naloxone solution for injection, 0.4 mg/mL of 1 ml; beasonide, suspension for dilution, 0.5 mg/ ml of 2 ml of 30 mg; nitroglycerin tablets, sublingual tablets of 0.5 mg of insulin; noradrenaline, a concentration for the infusion solution, 2 mg/mm of 4 ml of zinc; lasers, 670 mg/l of fluoxide; 2 ml/ml of 200 ml of flaxseed; 20 mg/mg of tablets for injections, 200 mg of folic acid; 5 ml of 20 ml of flintseed,

Days to Deadline
15 days
Closing: 02 Nov 2026, 00:00

Consortium & JV Partners

Matched
Need a Co-Bidder or Subcontractor?

Forming a Joint Venture increases technical eligibility and financial bonding capacity.

Post / Find JV Partners →

Key Procurement Details

Doc ref no. -
Notice Type Tender Notice
Bidding Type N/A
Publish Date 03 Oct 2026
Sector Pharmaceuticals, Healthcare Equipment and Services, Healthcare and Medicine
Document Fee Available in full notice
Bid Security Refer to documents
Funding Government Budget
Bid Opening Locked

Buyer Contact Information

Contact Details Locked

Nodal officer email, telephone, and website coordinates are unlocked upon free sign up.

Unlock Contact Details (Free) →